Show items per page
Elements: 16
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort Kim, Min; Snowden, Stuart; Suvitaival, Tommi; Ali, Ashfaq; ... Legido-Quigley, Cristina 2019
add to browser selection
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay Shi, Liu; Westwood, Sarah; Baird, Alison L; Winchester, Laura; ... Nevado-Holgado, Alejo J 2019
add to browser selection
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort Stamate, Daniel; Kim, Min; Proitsi, Petroula; Westwood, Sarah; ... Legido-Quigley, Cristina 2019
add to browser selection
Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework Mattsson, Niklas; Lönneborg, Anders; Boccardi, Marina; Blennow, Kaj; Hansson, Oskar 2017
add to browser selection
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment Herukka, Sanna-Kaisa; Simonsen, Anja Hviid; Andreasen, Niels; Baldeiras, Ines; ... Waldemar, Gunhild 2017
add to browser selection
Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia Simonsen, Anja Hviid; Herukka, Sanna-Kaisa; Andreasen, Niels; Baldeiras, Ines; ... Waldemar, Gunhild 2017
add to browser selection
Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis Disanto, Giulio; Barro, Christian; Benkert, Pascal; Naegelin, Yvonne; ... Lalive d'Epinay, Patrice 2017
add to browser selection
Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization Lewczuk, Piotr; Lelental, Natalia; Lachmann, Ingolf; Holzer, Max; ... Kornhuber, Johannes 2017
add to browser selection
Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations Lautner, Ronald; Insel, Philip S; Skillbäck, Tobias; Olsson, Bob; ... Zetterberg, Henrik 2017
add to browser selection
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers Jack, Clifford R (Jr); Bennett, David A; Blennow, Kaj; Carrillo, Maria C; ... Dubois, Bruno 2016
add to browser selection
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria Dubois, Bruno; Hampel, Harald; Feldman, Howard H.; Scheltens, Philip; ... Jack, Cliff R. 2016
add to browser selection
Alzheimer's disease Scheltens, Philip; Blennow, Kaj; Breteler, Monique M B; de Strooper, Bart; ... Van der Flier, Wiesje Maria 2016
add to browser selection
CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study Ewers, Michael; Mattsson, Niklas; Minthon, Lennart; Molinuevo, José L; ... Hampel, Harald 2015
add to browser selection
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects Toledo, Jon B.; Zetterberg, Henrik; van Harten, Argonde C.; Glodzik, Lidia; ... Trojanowski, John Q. 2015
add to browser selection
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria Dubois, Bruno; Feldman, Howard H; Jacova, Claudia; Hampel, Harald; ... Cummings, Jeffrey L 2014
add to browser selection
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial Dodel, Richard; Rominger, Axel; Bartenstein, Peter; Barkhof, Frederik; ... Jessen, Frank 2013